The company
China SXT Pharmaceuticals, Inc. - Class A
SXTC · Nasdaq
SXTC stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 97.9% below that average now. Pharmaceuticals: 37% of its 74 stocks in an uptrend (−1 points in four weeks); Health Care: 27% (−6 points in four weeks).
Statistics
- Last close, 22 Oct 2026
- 0.05 −34.25%
- 52-week range
- —
- Volume
- 57.49M
- Average volume (50 days)
- —
- Relative volume
- —
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 52
- Industry in uptrend
- 37% -1 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 2 (-1)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.
Pharmaceuticals: A minority of its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Price and volume
Daily bars to 22 Oct 2026: 26 sessions (1Y reaches back before the first session held here, 11 Sep 2026, so this is all of them). 1D is the last two sessions and 1W the last week of the same daily bars; nothing here is intraday.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Caitong International Asset Management Co., Ltdadded · filed 5 Aug 2026 | 2$4 | +1+100.0% |
| UBS Group AGunchanged · filed 13 Aug 2026 | 1$2 | 00.0% |
News
No headline names it lately.
Everyone who traded it
Nobody on record has traded it.
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.